New UK Market Surveillance Levy Could Cost Medtech Companies Millions Each Year
This article was originally published in The Gray Sheet
Executive Summary
The exact size of the fee is not yet known, but the UK's Medicines and Healthcare products Regulatory Agency apparently says it will be necessary to maintain fully functioning market oversight.